Avidity Biosciences
RNAM
#1830
Rank
โ‚ฌ10.08 B
Marketcap
65,25ย โ‚ฌ
Share price
0.00%
Change (1 day)
50.72%
Change (1 year)

EPS for Avidity Biosciences (RNAM)

EPS in 2025 (TTM): -3,71ย โ‚ฌ

According to Avidity Biosciences's latest financial reports the company's current EPS (TTM) is -3,75ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,59ย โ‚ฌ.

EPS history for Avidity Biosciences from 2020 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,71ย โ‚ฌ43.23%
2024-2,59ย โ‚ฌ
2022-2,98ย โ‚ฌ-9.02%
2021-3,28ย โ‚ฌ68.93%
2020-1,94ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,68ย โ‚ฌ-118.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,87ย โ‚ฌ-176.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-2,36ย โ‚ฌ-37.08%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-0,44ย โ‚ฌ-88.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-0,94ย โ‚ฌ-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-45,08ย โ‚ฌ 1,103.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,62ย โ‚ฌ-143.30%๐Ÿ‡บ๐Ÿ‡ธ USA